FIRST-CLL is a prospective study that evaluated frontline treatment selection among patients with chronic lymphocytic leukemia in Italy. This report aimed to quantify the relative impact of biological, clinical, logistical, and patient-related factors on therapeutic decisions by evaluating physician-assigned relevance scores for predefined parameters.
Read more at Hematological Oncology.
